Autism Spectrum Disorder Trial, Recruiting NCT07439276 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT07439276
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and adolescents between 8 and 16 years old
  • People whose native language is French
  • People whose parents or legal guardians have given their consent, and the child or adolescent has also agreed to take part
  • People who have not had any changes to certain psychiatric medications (such as antidepressants, anti-anxiety medications, antipsychotics, stimulants, or mood stabilizers) in the past 6 weeks
  • People with an IQ score above 70, as measured by a specific test called the WISC-V
  • People who have a diagnosis of Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder (ADHD), based on recognised diagnostic guidelines (DSM-5)
  • People who show signs of a neurodevelopmental condition but do not fully meet the criteria for one specific diagnosis, and who also show a pattern of difficulties across several areas of development meeting at least 5 specific elements (confirm with trial site for full details)

Who may not be able to join:

  • People who have an active neurological condition, such as epilepsy that is currently being treated or monitored

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dorothée Leunen, Assistance Publique - Hôpitaux de Paris

Phone: 0171196346

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 April 2026
Est. completion
1 April 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Overall social cognition score and scores per dimension, obtained on the multidimensional social cognition battery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov